Clinical Trial

Response to an Investigational Device in Patients With Restless Legs Syndrome

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-06; most recent amendment 2025-08-11.
Status change: Recruiting → Active, Not Recruiting 2025-08-11
Trial Details
NCT Number NCT06866132
Lead Sponsor Noctrix Health, Inc.
Conditions Restless Legs Syndrome
Enrollment 20 participants
Start Date 2025-03-11
Primary Completion 2025-08-04 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-15